PEPTIDE VACCINATION AGAINST CANCER TESTIS ANTIGENS IN COMBINATION WITH AZACITIDINE FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA: AN ONGOING PHASE I STUDY

被引：0
|
作者：
Holmberg, S. [1 ]
Gang, A. Ortved [1 ]
Svane, I. M. [2 ]
Dufva, I. Hogh [1 ]
Hadrup, S. Reker [3 ]
机构：
[1] Herlev Hosp, Dept Hematol, Herlev, Denmark
[2] Herlev Hosp, Ctr Canc Immune Therapy, Herlev, Denmark
[3] Tech Univ Denmark, Sect Vaccinol & Immunol, Copenhagen, Denmark
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1915
引用
收藏
页码：771 / 772
页数：2
相关论文
共 50 条
  • [21] Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study
    Walter, Roland B.
    Medeiros, Bruno C.
    Gardner, Kelda M.
    Orlowski, Kaysey F.
    Gallegos, Leonel
    Scott, Bart L.
    Hendrie, Paul C.
    Estey, Elihu H.
    HAEMATOLOGICA, 2014, 99 (01) : 54 - 59
  • [22] Phase I/II clinical study of topotecan and cytarabine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia and acute myeloid leukemia
    Weihrauch, MR
    Staib, P
    Seiberlich, B
    Hoffmann, M
    Diehl, V
    Tesch, H
    LEUKEMIA & LYMPHOMA, 2004, 45 (04) : 699 - 704
  • [23] Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study
    U Platzbecker
    F Braulke
    A Kündgen
    K Götze
    G Bug
    C Schönefeldt
    K Shirneshan
    C Röllig
    M Bornhäuser
    R Naumann
    J Neesen
    A Giagounidis
    W-K Hofmann
    G Ehninger
    U Germing
    D Haase
    M Wermke
    Leukemia, 2013, 27 : 1403 - 1407
  • [24] Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study
    Platzbecker, U.
    Braulke, F.
    Kuendgen, A.
    Goetze, K.
    Bug, G.
    Schoenefeldt, C.
    Shirneshan, K.
    Roellig, C.
    Bornhaeuser, M.
    Naumann, R.
    Neesen, J.
    Giagounidis, A.
    Hofmann, W-K
    Ehninger, G.
    Germing, U.
    Haase, D.
    Wermke, M.
    LEUKEMIA, 2013, 27 (06) : 1403 - 1407
  • [25] Determination of a Phase II Dose of Panobinostat in Combination with 5-Azacitidine in Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
    Ottmann, Oliver G.
    DeAngelo, Daniel J.
    Garcia-Manero, Guillermo
    Luebbert, Michael
    Jillella, Anand
    Sekeres, Mikkael A.
    Zahlten, Anita
    Squier, Margaret
    Acharyya, Suddhasatta
    Winiger, Ivo J.
    Fenaux, Pierre
    BLOOD, 2011, 118 (21) : 212 - 213
  • [26] A Phase 1 Dose Escalation Study of Milademetan in Combination with 5-Azacitidine (AZA) in Patients with Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
    DiNardo, Courtney D.
    Olin, Rebecca
    Ishizawa, Jo
    Sumi, Hiroyuki
    Xie, Jingdong
    Kato, Kazunobu
    Kumar, Prasanna
    Andreeff, Michael
    BLOOD, 2019, 134
  • [27] Azacitidine treatment for patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 3q abnormalities
    Wanquet, Anne
    Prebet, Thomas
    Berthon, Celine
    Sebert, Marie
    Roux, Clemence
    Kulasekararaj, Austin
    Micol, Jean-Baptiste
    Esterni, Benjamin
    Itzykson, Raphael
    Thepot, Sylvain
    Recher, Christian
    Delaunay, Jacques
    Dreyfus, Francois
    Mufti, Ghulam
    Fenaux, Pierre
    Vey, Norbert
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (10) : 859 - 863
  • [28] Infections in Patients with Myelodysplastic Syndrome/Acute Myeloid Leukemia Treated with Azacitidine: Report from a Single Center
    Quinto, Angela Maria
    De March, Elena
    Castelli, Monica
    Piazza, Francesco
    Adami, Fausto
    Semenzato, Gianpietro
    Binotto, Gianni
    BLOOD, 2014, 124 (21)
  • [29] INFECTIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA TREATED WITH AZACITIDINE: REPORT FROM A SINGLE CENTER
    Quinto, A. M.
    De March, E.
    Castelli, M.
    Binotto, G.
    Semenzato, G.
    Adami, F.
    HAEMATOLOGICA, 2015, 100 : 471 - 472
  • [30] A Phase 1b Study of Glasdegib in Combination with Azacitidine in Patients with Untreated Higher-Risk Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia
    Sekeres, Mikkael A.
    Schuster, Michael W.
    Joris, Magalie
    Krauter, Jurgen
    Maertens, Johan A.
    Gyan, Emmanuel
    Kovacsovics, Tibor
    Verma, Amit
    Vyas, Paresh
    Wang, Eunice S.
    Ma, Weidong Wendy
    Zeremski, Mirjana
    Kudla, Arthur
    Chan, Geoffrey
    Zeidan, Amer M.
    BLOOD, 2019, 134
12345